1H NMR analysis for metabolites in serum and urine from rats administrated chronically with La(NO3)3

被引:88
作者
Feng, JH
Li, XJ
Pei, FK [1 ]
Chen, X
Li, SL
Nie, YX
机构
[1] Chinese Acad Sci, Changchun Inst Appl Chem, Changchun 130022, Peoples R China
[2] Norman Bethune Univ Med Sci, Changchun 130021, Peoples R China
基金
中国国家自然科学基金;
关键词
biofluids; rare earth; nuclear magnetic resonance; metabolism;
D O I
10.1006/abio.2001.5471
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
H-1 NMR spectroscopy has been used to assess long-term toxicological effects of a rare earth. Male Wistar rats were administrated orally with La(NO3)(3) at doses of 0.1, 0.2, 2.0, 10, and 20 mg/kg body wt, resp., for 3-6 months. Urine was collected at 1, 2, and 3 months and serum samples were taken after 6 months. Numerous low-M-r metabolites in rats serum and rats urine, including creatinine, citrate, glucose, ketone bodies, trimethylamine N-oxide (TMAO), and various amino acids, were identified on 400- and 500-MHz H-1 NMR spectra. La3+-induced renal and liver damage is characterized by an increase in the amounts of the excreted ketone bodies, amino acids, lactate, ethanol, succinate, TMAO, dimethylamine, and taurine and a decrease in citrate, glucose, urea, and allantoin. Information on the molecular basis of the long-term toxicity of La(NO3)(3) was derived from the abnormal patterns of metabolite excretions. An assay of some biochemical indexes and analysis of some enzymes in plasma supported NMR results. (C) 2002 Elsevier Science.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 32 条
[1]  
CUI MZ, 1985, J CHIN RARE EARTH SO, V9, P28
[2]  
Evans C.H., 1990, BIOCH LANTHANIDES
[3]  
FANG JJ, 1993, GUIDE BIOCH EXPT
[4]  
GARTLAND KPR, 1989, MOL PHARMACOL, V35, P242
[5]   750 MHz H-1 NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease [J].
Holmes, E ;
Foxall, PJD ;
Spraul, M ;
Farrant, RD ;
Nicholson, JK ;
Lindon, JC .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 15 (11) :1647-1659
[6]  
Holmes E, 1998, NMR BIOMED, V11, P235, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<235::AID-NBM507>3.0.CO
[7]  
2-V
[8]  
*HUASH HOSP SHANGH, 1976, EXP DIAGN B
[9]  
KANG GF, 1998, CLIN BIOCH BIOCH ANA
[10]  
Lu R, 2000, CHIN J INORG CHEM, V16, P273